Cannabis Bioscience International Holdings, Inc.
Datakwaliteit: 100%
CBIH
OTC
Services
Engineering & Management Services
€ 0,00
▼
€ 0,00
(-20,00%)
Marktkapitalisatie: 5,81 M
Prijs
€ 0,00
Marktkapitalisatie
5,81 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -408.419,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)21,77%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-333,39%
Op. Margin-245,25%
Veiligheid
Debt / Equity
N/A
Current Ratio0,02
Interest Coverage-2,92
Waardering
PE (TTM)
-8,65
Onder sectorgemiddelde (-1,18)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (506 peers)
Sectorvergelijking
vs Services sector mediaan (506 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,7 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -15,8 |
| Net Margin % | -333,4 | -18,3 |
| Rev Growth 5Y % | — | 4,2 |
| D/E | — | 0,4 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 | — | 369.000,01 | — |
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,77% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 201.601,0 | Net Income (TTM) | -672.127,0 |
| ROE | N/A | ROA | -3272,84% |
| Gross Margin | 75,01% | Operating Margin | -245,25% |
| Net Margin | -333,39% | Free Cash Flow (TTM) | -408.419,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,02 |
| Interest Coverage | -2,92 | Asset Turnover | 9,82 |
| Working Capital | -1,11 M | Tangible Book Value | -1,36 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,65 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 28,84 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7,03% | ||
| Market Cap | 5,81 M | Enterprise Value | 6,10 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,00 | Revenue / Share | 0,00 |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 60,77% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 303.022,0 | 248.841,0 |
| Net Income | -548.820,0 | -651.345,0 |
| EPS (Diluted) | 0,00 | 0,00 |
| Gross Profit | 262.916,0 | 203.242,0 |
| Operating Income | -421.365,0 | -486.140,0 |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | 136.262,0 | 154.206,0 |
| Income Tax | — | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 31.880,0 | 57.162,0 |
| Total Liabilities | 1,20 M | 1,14 M |
| Shareholders' Equity | -1,16 M | -1,08 M |
| Total Debt | 286.187,0 | 256.415,0 |
| Cash & Equivalents | — | — |
| Current Assets | 29.085,0 | 21.492,0 |
| Current Liabilities | 945.963,0 | 881.908,0 |
{"event":"ticker_viewed","properties":{"ticker":"CBIH","listing_kind":"stock","pathname":"/stocks/cbih","exchange":"OTC","country":"US"}}